Targeted Inhibition of Adenosine-Pathway by Humanized Antibodies to Enhance the Cancer Immunity

Time: 10:00 am
day: Day Two

Details:

• Understanding the rationale of the target

• Highlighting the developing products and combination with checkpoint inhibition

• Discussing the challenges for clinical development

Speakers: